维普中文期刊产品整合服务
14篇 您的检索式:作者名="Schiegnitz"
    题名 作者 年代 出处 被引量
1Augmentation procedures using bone subtitute materials or autogenous bone-a systematic review and meta-analysis 显示文摘A1-Nawas B Schiegnitz E 2014Eur J Oral Implantol2014,7,2:1
2GDF 15 as ananti-apoptotic, diagnostic and prognostic marker in oralsquamous cell carcinoma 显示文摘Schiegnitz E Kammerer P W Koch F P 2012Oral Oncol2012,48,7:1
3Growth differentiation factor 15 acts anti-apoptotic and pro-hypertrophic in adult cardiomyocytes显示文摘Heger J Schiegnitz E von Waldthausen D 0,,01:1
4Myeloablativeradiochemotherapy followed by autologous stem celltransplantation in first remission prolongs progression-free survival in follicular lymphoma : results of aprospective, randomized trial of the German Low-GradeLymphoma Study Group显示文摘Lenz G Dreyling M Schiegnitz E 2004Blood2004,104,9:1
5Clinical effi- cacy of a computerised device(STATM) and a pressure syringe (VarioJect INTRATM) for intraligamentary anaesthesia 显示文摘Kammerer PW Schiegnitz E yon Haussen T 2015EurJDentEduc2015,19,1:1
6Growth differentiation factor 15 acts anti-apoptotic and prohypertrophic inadult cardiomyocytes显示文摘Heger J Schiegnitz E von WD 2010J Cell Physiol2010,224,1:1
7Moderate increase of secondary hematologic malignancies after myeloablative radiochemotheraphy and autologous stem-cell transplantation in patients with indolent lymphoma:results of a prospective randomized trail of Low Grade Lymphoma Study Group显示文摘Lenz G Dreyling M Schiegnitz F 2004J Clin Oncol2004,22,24:1
8Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lyre phoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group 显示文摘Lenz G Dreyling M Schiegnitz E 2004Blood2004,104,9:1
9Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression- free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group 显示文摘Lenz G Dreyling M Schiegnitz E 2004Blood2004,104,9:1
10Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma - results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group (GLSG) 显示文摘Lenz G Dreyling M Schiegnitz E 2004Blood2004,104,9:1
11GDF 15 as an anti-apoptotic, diagnostic and prognostic marker in oral squamous cell carcinoma 显示文摘Schiegnitz E Kammerer PW Koch FP 2012Oral Oncol2012,48,7:1
12Moderate increase of sec- ondary hematologic malignancies after myeloablative radiochemo- therapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of tile German Low Grade Lymphoma Study Group显示文摘Lenz G Dreyling M Schiegnitz E 2004J Clin Oncol2004,22,24:1
13Oral rehabilita- tion with dental implants in irradiated patients : a meta-analysis on implant survival显示文摘Schiegnitz E A1-Nawas B Kammerer PW 2014Clin Oral Investig2014,18,3:1
14有关口腔鳞状细胞癌生物标志物系统综述和Meta分析文献的质量评估显示文摘目的:评估有关口腔鳞状细胞癌(Oral Squamous Cell Carcinoma,OSCC)生物标志物系统综述和Meta分析文献的方法学质量。材料与方法:系统检索从1990年1月至2014年3月所发表的有关OSCC系统综述和Meta分析文献。从全文中提取出这些系统综述所报道的方法学相关方面的数据。采用AMSTAR量表和Glenny量表对纳入系统综述和meta分析文献的方法学质量进行评估。结果:检索电子数据库共得到1098篇摘要.经过筛选,共纳入7篇文献进行质量评估。所有系统综述AMSTAR量表的平均得分为4.6±1.9(2-7分,总分为11分),Glenny量表的平均得分为7.1±16(5-9分,总分为14分)。采用Spearman相关分析得到的结果表明,AMSTAR量表得分和Glenny量表得分高度正相关(rs=0.757;p=0,049)。影响因子大于2.5的文献采用的方法质量更高,且具有统计学意义(AMSTAR:p=O031;Glenny:p=0.046)。此外2007年后发表的系统综述AMSTAR量表和Glenny量表得分更高.但不具有统计学意义(AMSTAR:p=0.076;Glenny:p=0.232)。结论:OSCC生物标志物相关系统综述和meta分析文献在方法学、结构方面具有明显的差异性,这增加了偏倚风险,使得文献得出的结论无效。诸如AMSTAR或Glenny之类的量表或许可提高系统综述的质量和一致性,从而增加其临床有效性和相关应用实践。Eik Schiegnitz Peer W.Kammerer Bilal AI-Nawas 李杰(译) 张珊珊(审) 郑树国(审) 2018中国口腔医学继续教育杂志2018,21,3:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费